Aclaris Therapeutics, Inc.

Q1 2020 13F Holders

Symbol
ACRS
CUSIP
00461U105
Type
Equity
Class
COM
Num filings
74
Total reported value, excl. options
$33.4 M
Manager Report Date Value ($000) Shares Option Type